Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Academic Medical Center of the University of Amsterdam (AMC), the Royal Tropical Institute (KIT), the Amsterdam Institute for Global Health and Development (AIGHD), Roland Berger Strategy Consultants and Top Institute Pharma have come together to launch The European Solutions Enterprise for Neglected Diseases (euSEND) in the Netherlands.
Subscribe to our email newsletter
euSEND brings together universities, pharma firms, other international research organizations and product development partnerships to encourage development of solutions for neglected tropical diseases.
The Dutch initiative builds, amongst others, on the public-private partnership nature of Top Institute Pharma, an organization dedicated to providing cross-disciplinary research within the framework of the WHO Priority Medicines report.
As the first showcase of euSEND, three projects are being initiated with FIND (Foundation for Innovative New Diagnostics), a not-for-profit foundation focusing on improving the diagnosis of diseases in developing countries.
The projects will focus on leishmaniasis, trachoma and tuberculosis.
Other partners involved are Leiden University Medical Center and the Royal Tropical Institute (KIT).
euSEND program manager Jayasree Iyer said euSEND arranges for methods and technologies proven successful with other diseases, to be tried in the research into neglected tropical diseases, to produce innovative solutions.
Jorg Janssen of Top Institute Pharma said they want to greatly speed up the development of medicinal products and diagnostic kits for tropical diseases while reducing the associated risk for partners and investors.